What if the brain's response to stress could be read not in fleeting neurotransmitter bursts, but in the quieting of genes ...

Pancreas development in pigs resembles humans much more closely than does the established mouse model. An international team ...

BMY's growth-driving portfolio increased 17% year-over-year, prompting an upward revision in 2025 revenue guidance and ...

How do stem cells know what to become?Nearly three decades after scientists isolated the first human embryonic stem cells, researchers are still ...

In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...

Researchers probe charged polymer droplets to reveal how their nanoscale behavior could shape future drug delivery and ...

Demonstrated feasibility of effective DNA delivery with Company's xPhore™ nanoparticle technologyDNA delivery technology to be offered as GenePhore™ to biotech / pharma companiesAddressing large and ...

Good afternoon, and welcome to Sarepta's Third Quarter 2025 Financial Results Conference Call. As a reminder, today's program is being recorded. At this time, I'll turn the call over to Tam Thornton, ...

OCALA, Fla., Nov. 03, 2025 (NYSE American: AIM) ("AIM" or the "Company") today announced that the European Patent Office has officially granted AIM's European Patent No. 4,096,675, titled "Composition ...

The most dangerous animal in the world just got easier to study-and perhaps defeat one day.

SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...